Cargando…
Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma
There is an urgent need for new biomarkers that address the shortcomings of current screening methods which fail to detect a large proportion of cases with hepatocellular carcinoma (HCC) at early stage. To develop a robust, multiple‐biomarker panel based on multiple reaction monitoring–mass spectrom...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193127/ https://www.ncbi.nlm.nih.gov/pubmed/32363324 http://dx.doi.org/10.1002/hep4.1500 |
_version_ | 1783528132820598784 |
---|---|
author | Yeo, Injoon Kim, Gi‐Ae Kim, Hyunsoo Lee, Ji Hyeon Sohn, Areum Gwak, Geum‐Youn Lee, Jeong‐Hoon Lim, Young‐Suk Kim, Youngsoo |
author_facet | Yeo, Injoon Kim, Gi‐Ae Kim, Hyunsoo Lee, Ji Hyeon Sohn, Areum Gwak, Geum‐Youn Lee, Jeong‐Hoon Lim, Young‐Suk Kim, Youngsoo |
author_sort | Yeo, Injoon |
collection | PubMed |
description | There is an urgent need for new biomarkers that address the shortcomings of current screening methods which fail to detect a large proportion of cases with hepatocellular carcinoma (HCC) at early stage. To develop a robust, multiple‐biomarker panel based on multiple reaction monitoring–mass spectrometry with high performance in detecting early‐stage HCC within at‐risk populations. In the discovery set, 150 samples were analyzed to identify candidate biomarkers. The resulting list of candidates was tested in the training set (713 samples) to establish a multimarker panel, which was evaluated in the validation set (305 samples). We identified 385 serum HCC biomarker candidates in the discovery set and developed a multimarker panel consisting of 28 peptides that best differentiated HCC from controls. The area under the receiver operating characteristic curve of multimarker panel was significantly higher than alpha‐fetoprotein (AFP) in the training (0.976 vs. 0.804; P < 0.001) and validation (0.898 vs. 0.778; P < 0.001) sets. In the validation set, this multimarker panel, compared with AFP, showed significantly greater sensitivity (81.1% vs. 26.8%; P < 0.001) and lower specificity (84.8% vs. 98.8%; P < 0.001) in detecting HCC cases. Combining AFP with the multimarker panel did not significantly improve the area under the receiver operating characteristic curve compared with the panel alone in the training (0.981 vs. 0.976; P = 0.37) and validation set (0.906 vs. 0.898; P = 0.75). Conclusion: The multiple reaction monitoring–mass spectrometry multimarker panel consisting of 28 peptides discriminates HCC cases from at‐risk controls with high performance and may have potential for clinical application in HCC surveillance. |
format | Online Article Text |
id | pubmed-7193127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71931272020-05-01 Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma Yeo, Injoon Kim, Gi‐Ae Kim, Hyunsoo Lee, Ji Hyeon Sohn, Areum Gwak, Geum‐Youn Lee, Jeong‐Hoon Lim, Young‐Suk Kim, Youngsoo Hepatol Commun Original Articles There is an urgent need for new biomarkers that address the shortcomings of current screening methods which fail to detect a large proportion of cases with hepatocellular carcinoma (HCC) at early stage. To develop a robust, multiple‐biomarker panel based on multiple reaction monitoring–mass spectrometry with high performance in detecting early‐stage HCC within at‐risk populations. In the discovery set, 150 samples were analyzed to identify candidate biomarkers. The resulting list of candidates was tested in the training set (713 samples) to establish a multimarker panel, which was evaluated in the validation set (305 samples). We identified 385 serum HCC biomarker candidates in the discovery set and developed a multimarker panel consisting of 28 peptides that best differentiated HCC from controls. The area under the receiver operating characteristic curve of multimarker panel was significantly higher than alpha‐fetoprotein (AFP) in the training (0.976 vs. 0.804; P < 0.001) and validation (0.898 vs. 0.778; P < 0.001) sets. In the validation set, this multimarker panel, compared with AFP, showed significantly greater sensitivity (81.1% vs. 26.8%; P < 0.001) and lower specificity (84.8% vs. 98.8%; P < 0.001) in detecting HCC cases. Combining AFP with the multimarker panel did not significantly improve the area under the receiver operating characteristic curve compared with the panel alone in the training (0.981 vs. 0.976; P = 0.37) and validation set (0.906 vs. 0.898; P = 0.75). Conclusion: The multiple reaction monitoring–mass spectrometry multimarker panel consisting of 28 peptides discriminates HCC cases from at‐risk controls with high performance and may have potential for clinical application in HCC surveillance. John Wiley and Sons Inc. 2020-03-13 /pmc/articles/PMC7193127/ /pubmed/32363324 http://dx.doi.org/10.1002/hep4.1500 Text en © 2020 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Yeo, Injoon Kim, Gi‐Ae Kim, Hyunsoo Lee, Ji Hyeon Sohn, Areum Gwak, Geum‐Youn Lee, Jeong‐Hoon Lim, Young‐Suk Kim, Youngsoo Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma |
title | Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma |
title_full | Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma |
title_fullStr | Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma |
title_full_unstemmed | Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma |
title_short | Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma |
title_sort | proteome multimarker panel with multiple reaction monitoring–mass spectrometry for early detection of hepatocellular carcinoma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193127/ https://www.ncbi.nlm.nih.gov/pubmed/32363324 http://dx.doi.org/10.1002/hep4.1500 |
work_keys_str_mv | AT yeoinjoon proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT kimgiae proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT kimhyunsoo proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT leejihyeon proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT sohnareum proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT gwakgeumyoun proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT leejeonghoon proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT limyoungsuk proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma AT kimyoungsoo proteomemultimarkerpanelwithmultiplereactionmonitoringmassspectrometryforearlydetectionofhepatocellularcarcinoma |